- $2.05bn
- $2.13bn
- $120.25m
Annual cashflow statement for Mesoblast, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 10 | 9.39 | 12.4 | 10.2 | 92.4 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -65.8 | -63.3 | -48.5 | -50 | -43.8 |
| Capital Expenditures | -0.157 | -0.264 | -0.271 | -0.68 | -0.833 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.075 | 0.07 | 0.174 | 0.8 | -0.19 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.232 | -0.194 | -0.097 | 0.12 | -1.02 |
| Financing Cash Flow Items | -11.8 | -11.5 | -11.6 | -10.9 | -23.6 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -9.87 | 74.5 | 40.3 | 147 | -15.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -76.4 | 10.9 | -8.36 | 98.6 | -58.6 |